PROM1 and breast cancer: In another study, the analysis of EVsfrom the plasma of BC donors identified 10 candidate biomarkers, whose levelswere higher in BC patients than in healthy subjects (CD3, CD56, CD2, CD25, CD9,CD44, CD326, CD133/1, CD142, and CD14).